LPA and coronary artery disorder: Our result is similar to a study by Nicholls et al., who determined that LPA SNPs rs2048327, rs3127599, rs7767084 and rs10755578 as well as haplotypes correlated to plasma Lp(a) levels, and Lp(a) levels ≥30 mg/dl were associated with MACE in stable CAD patients during a 3-year follow-up; however, this group did not observe any association of the LPA SNPs/haplotypes with increased prospective MACE risk.